Event Abstract Back to Event A single psychotomimetic dose of ketamine disrupts corticothalamic dynamics Paul Anderson1, 2, 3*, Terence O'Brien1, Nigel C. Jones1 and Didier Pinault2, 3 1 University of Melbourne, Department of Medicine (Royal Melbourne Hospital), Australia 2 Université de Strasbourg, Faculté de Médecine, France 3 INSERM U666, physiopathologie et psychopathologie cognitive de la schizophrénie, France Sensory and cognitive deficits are common in schizophrenia. The underlying anatomo-functional mechanisms remain elusive. There is a growing body of literature indicating the involvement of dysfunctional thalamic networks in the pathophysiology of schizophrenia, including disturbances in function-related gamma frequency (30-80 Hz) oscillations. A postulated mechanism of these impairments is the reduced N-Methyl d-Aspartate receptor (NMDAr) activation at glutamatergic synapses on GABAergic interneurons. Ketamine is a non-competitive NMDAr antagonist that when administered at sub-anaesthetic doses in humans and rodents produces symptoms reminiscent of psychosis and also induces aberrant gamma oscillations in cortical and sub-cortical structures, including the thalamus. Corticothalamic and thalamocortical pathways are glutamatergic and work together during brain operations, including during cognition and sensory information processing. Corticothalamic pathways originate from layer VI and innervate simultaneously GABAergic thalamic reticular nucleus neurons and thalamocortical neurons of the dorsal thalamus. The goal of the present study was to explore the spatiotemporal dynamics of the corticothalamic and thalamocortical pathways in the rat somatosensory system under physiological (vehicle) and pathological (ketamine) conditions. We conducted under light anesthesia (4) multisite cell-to-network recordings in the rat somatosensory thalamus. Its background activity was challenged by stimulation of the vibrissae. Sensory stimulation evoked a short-latency (3.3 ± 0.1 ms, n=30 from 3 animals) prethalamic response and a longer latency (9.6 ± 0.1 ms, n = 30 from 3 animals) corticothalamic response. A single injection of ketamine (2.5 mg/kg, sc) significantly increased the power of gamma oscillations (~240 % of vehicle, p < 0.001) and decreased the amplitude of the sensory-evoked corticothalamic response (vehicle condition: -0.35 ± 0.02 mV; ketamine condition: -0.26 ± 0.05 mV, p < 0.001, n = 20). In conclusion, the present results support the hypothesis that the psychotomimetic effects of ketamine are characterized by a reduction of the sensory signal-to-gamma noise ratio in corticothalamic systems. Acknowledgements Paul Anderson is supported by an Australian Rotary Health PhD scholarship Keywords: gamma oscillations, Ketamine, Schizophrenia, sensory processing, Thalamus Conference: Bernstein Conference 2012, Munich, Germany, 12 Sep - 14 Sep, 2012. Presentation Type: Poster Topic: Sensory processing and perception Citation: Anderson P, O'Brien T, Jones NC and Pinault D (2012). A single psychotomimetic dose of ketamine disrupts corticothalamic dynamics. Front. Comput. Neurosci. Conference Abstract: Bernstein Conference 2012. doi: 10.3389/conf.fncom.2012.55.00141 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 11 May 2012; Published Online: 12 Sep 2012. * Correspondence: Mr. Paul Anderson, University of Melbourne, Department of Medicine (Royal Melbourne Hospital), Melbourne, Australia, p.anderson2@student.unimelb.edu.au Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Paul Anderson Terence O'Brien Nigel C Jones Didier Pinault Google Paul Anderson Terence O'Brien Nigel C Jones Didier Pinault Google Scholar Paul Anderson Terence O'Brien Nigel C Jones Didier Pinault PubMed Paul Anderson Terence O'Brien Nigel C Jones Didier Pinault Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.